Nuclear Medicine: Page 364

Palatin suspends NeutroSpec distribution
By AuntMinnie.com staff writers
Contrast agent developer Palatin Technologies said it is voluntarily suspending sales, marketing, and distribution activities of its NeutroSpec radiopharmecutical imaging agent as a result of recently raised safety concerns.
December 18, 2005
Siemens offers reward for stolen isotope
By AuntMinnie.com staff writers
Siemens Medical Solutions is offering a $1,000 reward for the return of a small container of radioactive material used to calibrate nuclear medicine imaging equipment.
December 13, 2005
Draxis to repurchase stock
By AuntMinnie.com staff writers
The board of directors of radiopharmaceutical developer Draxis Health has authorized the repurchase of up to 3.5 million common shares of stock.
December 7, 2005
PET/CT shows potential for detecting unknown primary cancers
By Jonathan S. Batchelor
Detecting the primary lesion in patients presenting with cancer and an unknown primary is one of the more demanding tasks in diagnostic medical imaging. At the recent RSNA conference in Chicago, a pair of presentations put PET/CT to the task of detecting unknown primary cancers.
December 7, 2005
Dilon partners for European, Canadian expansion
By AuntMinnie.com staff writers
Gamma camera developer Dilon Technologies reported that the first European installation of its Dilon 6800 gamma camera will be at the Royal Free Hospital in London, with more installations to follow in Europe and Canada as the result of recent distribution partnerships.
December 5, 2005
Schering may sell CIS bio radiopharma unit
By AuntMinnie.com staff writers
German contrast media firm Schering said it is "reviewing strategic alternatives" for its CIS bio International radiopharmaceutical business, with the possibility of selling off the division.
December 4, 2005
Palatin, Tyco warn of NeutroSpec health risk
By AuntMinnie.com staff writers
Palatin Technologies and partner Tyco Healthcare said they have informed the healthcare community about a potential health risk associated with its NeutroSpec radiopharmaceutical imaging agent.
December 4, 2005
Naviscan raises $6.5 million, moves headquarters
By AuntMinnie.com staff writers
PET developer Naviscan PET Systems has completed a $6.5 million Series B round of financing.
November 28, 2005
IBA begins distribution of I-124 MIBG
By AuntMinnie.com staff writers
Ion Beam Applications (IBA), of Louvain-la-Neuve, Belgium, has begun worldwide distribution of iodine-124 meta-iodobenzlguanidine (I-124 MIBG) through its U.S. subsidiary Eastern Isotopes in Sterling, VA.
November 28, 2005
GE to supply UPPI
By AuntMinnie.com staff writers
GE Healthcare has signed a multiyear strategic agreement with United Pharmacy Partners (UPPI) to provide its PET radiopharmacy technology to UPPI members across the U.S.
November 27, 2005
MDS Nordion collaborates with GSK
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion of Kanata, Ontario, is partnering with GlaxoSmithKline (GSK) to supply and manufacture the radiopharmaceutical component iodine-131 (I-131) used in Bexxar therapy.
November 26, 2005
CardiArc seeks clearance for SPECT
By AuntMinnie.com staff writers
Cardiac imaging device developer CardiArc reported that it submitted a premarket notification 510(k) application with the Food and Drug Administration for a SPECT imaging device last month.
November 22, 2005
Previous Page
Page 364 of 439
Next Page